Specifically, persistent activation of Nrf2 was associated with accumulation of p62, thereby contributing to HCC progression and inducing robust production of GSH that results in chemoresistance and increases the proliferative capacity of hepatoma cells [86]. Here, NFE2L2 is linked to hepatocellular carcinoma.